Breast Cancer Trial, Recruiting (NCT05598879)

Breast Cancer Trial, Recruiting NCT05598879 Sponsor: The Cleveland Clinic Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05598879 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older who are having their first-ever consultation with a cardio-oncology specialist (a doctor who looks after the heart health of cancer patients).
People with breast cancer who are attending a new cardio-oncology appointment.
People with Hodgkin's lymphoma or non-Hodgkin's lymphoma who are attending a new cardio-oncology appointment.
People with acute or chronic leukemia (a type of blood cancer) who are attending a new cardio-oncology appointment.
People with multiple myeloma or AL amyloidosis (conditions affecting blood cells and organs) who are attending a new cardio-oncology appointment.
People receiving immune checkpoint inhibitor cancer treatment who are attending a new cardio-oncology appointment for a heart assessment.

Who may not be able to join:

People who have already been seen and followed up by this trial's cardio-oncology team in the past.
People under 18 years of age.
People who are unable or unwilling to give their consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Diego Sadler, MD FACC, The Cleveland Clinic

Phone: 5613898833

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05598879

Sponsor: The Cleveland Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 5613898833

More information: https://clinicaltrials.gov/study/NCT05598879

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older who are having their first-ever consultation with a cardio-oncology specialist (a doctor who looks after the heart health of cancer patients).
People with breast cancer who are attending a new cardio-oncology appointment.
People with Hodgkin's lymphoma or non-Hodgkin's lymphoma who are attending a new cardio-oncology appointment.
People with acute or chronic leukemia (a type of blood cancer) who are attending a new cardio-oncology appointment.
People with multiple myeloma or AL amyloidosis (conditions affecting blood cells and organs) who are attending a new cardio-oncology appointment.
People receiving immune checkpoint inhibitor cancer treatment who are attending a new cardio-oncology appointment for a heart assessment.

Who may not be able to join:

People who have already been seen and followed up by this trial's cardio-oncology team in the past.
People under 18 years of age.
People who are unable or unwilling to give their consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Cleveland Clinic

Registry

ClinicalTrials.gov

Start date

1 July 2022

Est. completion

1 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cardiotoxicity; New cardiovascular events; Cardiovascular death.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov